Lidocaine is routinely applied to open wounds in clinical settings, particularly for numbing lacerations before stitching and for managing pain in chronic wounds like leg ulcers. It is not, however, a substance you can use casually on broken skin the way you might dab it on an intact surface. Open wounds absorb lidocaine far more rapidly than unbroken skin does, which changes both the benefits and the risks. The answer to whether you can use it is less about permission and more about how, how much, and on what kind of wound.
Why Open Wounds Change the Equation
Intact skin acts as a barrier. Lidocaine applied to unbroken skin penetrates slowly and stays relatively local, with measurable drug concentrations mostly limited to about a centimeter of depth in the first couple of hours. Once that barrier is gone, the drug enters the bloodstream much faster. A cut, scrape, or burn exposes tissue that has no outer layer of dead skin cells to slow absorption, and the increased blood flow that comes with any wound speeds things along further. This is why the same cream that barely registers on healthy skin can produce clinically meaningful blood levels when spread over a raw surface.
That faster absorption is a double-edged sword. It means the numbing effect kicks in quickly and works well, which is exactly what you want when someone needs wound care. But it also means the window between a helpful dose and a dangerous one narrows. The larger and more raw the wound, the narrower that window becomes.
Where Lidocaine on Open Wounds Is Standard Practice
Emergency departments commonly use a topical gel containing lidocaine, epinephrine, and tetracaine (known as LET gel) directly on lacerations before suturing or gluing them shut. Studies in children have shown that applying LET gel to minor lacerations before closing them with tissue adhesive reduces pain and increases the number of pain-free repairs.1PubMed Central. Efficacy of pain control with topical lidocaine-epinephrine-tetracaine during laceration repair with tissue adhesive in children: a randomized controlled trial The gel is applied directly into and around the wound, left in place for about 20 to 30 minutes, and provides enough numbing that many patients, especially children, can avoid the needle stick of an injected anesthetic altogether.
A randomized trial comparing LET solution to LET gel found that the gel achieved complete anesthesia in about 85% of patients.2PubMed. Topical anesthesia for pediatric lacerations: a randomized trial of lidocaine-epinephrine-tetracaine solution versus gel That is good enough that many emergency physicians consider topical LET their first choice for simple lacerations on the face and scalp, where the blood supply is rich and absorption is predictable. For wounds on the extremities, where blood flow is lower, topical preparations sometimes fall short and injectable lidocaine becomes necessary.
When injection is needed, a recent randomized trial found that applying a lidocaine-prilocaine cream to a laceration before injecting additional lidocaine produced pain scores that were statistically no different from injection alone, with mean maximum pain scores of roughly 4.6 versus 4.3 on a 10-point scale.3PubMed. Topical anesthetic cream vs. lidocaine infiltration for superficial laceration repair in the emergency department: a randomized clinical trial In other words, topical cream alone can sometimes do the job, but the advantage over a well-placed injection is not dramatic for straightforward wounds.
Chronic Wounds and Ongoing Pain
Lacerations are acute injuries that get stitched and heal. Chronic wounds like venous leg ulcers, pressure sores, and non-healing surgical wounds present a different problem: the pain is persistent and often worsens during dressing changes. Topical lidocaine has a meaningful role here. A systematic review found that lidocaine-prilocaine cream significantly improved wound-related pain compared with other topical agents studied for chronic leg ulcers.4PubMed. Topical Analgesic and Local Anesthetic Agents for Pain Associated with Chronic Leg Ulcers: A Systematic Review
A separate observational study of 78 patients with various wound types, including traumatic wounds, venous ulcers, and post-surgical wounds, found that 5% lidocaine cream applied directly to the wound reduced average pain scores from about 6.7 to 3.0 on a 10-point scale over the treatment period.5PubMed. 5% Lidocaine Hydrochloride Cream for Wound Pain Relief: A Multicentre Observational Study That is a clinically significant drop for patients whose daily wound care would otherwise be agonizing.
Burns Are a Special Case
Burns destroy the skin’s protective barrier over potentially large areas, which means absorption of anything applied topically can be dramatic. Despite this, lidocaine has been studied on partial-thickness burns. One early study treated burns covering up to 28% of total body surface area with topical lidocaine and found measurable plasma levels that remained steady over four hours, with significant pain reduction and no cardiovascular or infectious complications.6PubMed. Topical lidocaine in the treatment of partial-thickness burns The plasma level reached in that study (about 5.8 micrograms per milliliter) was within the range where mild systemic side effects like dizziness or tinnitus can begin, which highlights how tight the margins are.
A systematic review of EMLA cream (a lidocaine-prilocaine combination) in burns concluded that the product is safe and provides adequate pain relief in adults when applied to smaller burns, but urged caution with children. Younger patients are more vulnerable to systemic toxicity, and cases of prilocaine-induced methemoglobinemia (where the blood’s ability to carry oxygen is impaired) have been reported when high doses were applied over large burn areas.7PubMed. EMLA cream in burns: A systematic review of safety, analgesic efficacy, and effects on burn pathophysiology
Does Lidocaine Interfere with Healing?
This is the question that gets less attention in emergency rooms but matters a great deal if you are caring for a wound over days or weeks. At the cellular level, the picture is not entirely reassuring. Lab studies consistently show that lidocaine has concentration-dependent toxic effects on fibroblasts, the cells responsible for building the collagen scaffold that holds a healing wound together.
One study exposing human fibroblasts to lidocaine, bupivacaine, and ropivacaine found that all three caused dose-dependent decreases in cell survival, mitochondrial activity, and proliferation, with the effects worsening with longer exposure times.8PubMed Central. In vitro exposure of human fibroblasts to local anaesthetics impairs cell growth Another study on oral mucosal fibroblasts confirmed that lidocaine can alter cell viability even at low concentrations, with concentrations starting at 1% capable of hindering normal cell function. The researchers concluded that the lowest effective concentration should always be used.9PubMed. An early and late cytotoxicity evaluation of lidocaine on human oral mucosa fibroblasts
Age matters too. A study comparing young and aged human fibroblasts found that lidocaine inhibited proliferation in cells from older donors but not from younger ones. It also reduced collagen production: collagen III was decreased in both age groups, while collagen I dropped only in the older cells.10PubMed Central. Lidocaine impairs proliferative and biosynthetic functions of aged human dermal fibroblasts If you are an older adult with a chronic wound that is already struggling to heal, repeated topical lidocaine may be working against the repair process at the same time it is easing your pain.
How much this matters in real wounds (as opposed to cells in a dish) is harder to pin down. Animal studies have been somewhat reassuring. A study in dogs found that lidocaine and bupivacaine applied to surgical wounds before suturing did not produce deleterious effects on skin healing at the doses and concentrations used.11PubMed Central. Topical application of lidocaine or bupivacaine in the healing of surgical wounds in dogs A rat study also found that lidocaine affected collagen formation and decreased the initial quantity of mast cells at wound sites, but these changes did not necessarily translate to visibly impaired healing over the study period. The tension here is real: in the test tube, lidocaine clearly harms the cells that drive wound repair. In living tissue, the body may compensate well enough that a single or short-term application makes no practical difference. Repeated daily applications to a chronic wound over weeks are a different calculation, and the data on that scenario are thinner.
The Antimicrobial Angle
You will sometimes hear that lidocaine has antibacterial properties, which sounds like a bonus for open wounds. The evidence is genuinely mixed. One widely cited study found that lidocaine showed dose-dependent inhibition of growth across multiple bacterial strains, including those commonly associated with wound infections, with gram-negative organisms being the most sensitive.12PubMed. Antimicrobial activity of lidocaine against bacteria associated with nosocomial wound infection A more recent in-vitro study confirmed concentration-dependent antimicrobial effects, with 2% lidocaine producing notable inhibition of Staphylococcus species including MRSA.13PubMed Central. Lidocaine Shows Significant Antimicrobial Effects Against Staphylococcus Species
But another study found that lidocaine at multiple concentrations produced no zone of inhibition at all against Staphylococcus epidermidis, Staphylococcus aureus, or Bacillus subtilis.14The Open Pain Journal. Antimicrobial Activity of Lidocaine, Bupivacaine, Mepivacaine and Ropivacaine on Staphylococcus epidermidis, Staphylococcus aureus and Bacillus subtilis The discrepancy likely comes down to differences in testing methods, concentrations, and bacterial strains. The practical takeaway is that you should not rely on lidocaine as an antimicrobial agent for wound care. If it has any antibacterial effect at clinical concentrations, it is too inconsistent to count on. Proper wound cleaning and, when indicated, actual antibiotics are what prevent infection.
Toxicity Risks and Dosing Limits
The most serious danger of putting lidocaine on an open wound is systemic toxicity. If enough drug enters the bloodstream, it can cause symptoms ranging from numbness around the mouth and ringing in the ears to seizures and cardiac arrest. The risk scales with three things: the concentration of the product, the area you cover, and the condition of the skin barrier.
Guidelines from the American Academy of Dermatology state that the maximum safe dose of lidocaine for injection is about 4.5 mg/kg without epinephrine and about 7 mg/kg with epinephrine in adults. In children, the recommended limits are lower: roughly 1.5 to 2 mg/kg without epinephrine and 3 to 4.5 mg/kg with epinephrine.15Journal of the American Academy of Dermatology. Guidelines of care for the management of local anesthesia in office-based dermatologic surgery These numbers were developed for injection into intact tissue, not for application to raw wound beds, where absorption can be faster and less predictable. There is no universally agreed-upon “maximum safe dose” for topical application to open wounds specifically, which is part of why clinical judgment matters so much.
The most alarming illustration of this risk involves a 22-month-old toddler whose parents applied a thick layer of 4% lidocaine cream (an over-the-counter product) to superficial abrasions on the child’s legs and back. The child developed seizures that would not stop and went into cardiac arrest. The abrasions allowed the lidocaine to be absorbed systemically at a rate far beyond what intact skin would have permitted. This case underscores that broken skin in children is a particularly dangerous combination with topical lidocaine, especially at higher concentrations and over large areas.
Methemoglobinemia is another concern, particularly with combination products like EMLA cream that contain prilocaine alongside lidocaine. In this condition, a metabolite of prilocaine alters hemoglobin so it cannot release oxygen to tissues effectively. Cases have been reported in children, including one involving an 8-year-old girl who developed methemoglobinemia after EMLA application.16PubMed. Methemoglobinemia induced by lidocaine-prilocaine cream The risk increases when these creams are applied to large areas of broken skin or left on for extended periods.
Buffered Lidocaine for Wound Injection
When lidocaine is injected into a wound rather than applied topically, the sting of the injection itself is a common complaint. Standard lidocaine solutions are acidic, which contributes to the burning sensation. Mixing lidocaine with sodium bicarbonate (buffering it) raises the pH closer to that of body tissue and has been shown to make the injection less painful.17PubMed. Comparison of wound infection rates using plain versus buffered lidocaine for anesthesia of traumatic wounds That same study found no difference in wound infection rates between buffered and plain lidocaine, suggesting the modification does not introduce new risks.
However, a separate trial looking at buffered lidocaine for incision and drainage of abscesses found no significant difference in pain of injection compared with standard lidocaine, and most patients experienced moderate-to-severe pain during the procedure regardless of which formulation was used.18PubMed. Buffered lidocaine for incision and drainage: a prospective, randomized double-blind study Buffering seems to help with simple laceration injections but may not make a meaningful difference when the procedure itself overwhelms whatever comfort the injection provides.
When Bupivacaine Might Be a Better Choice
One practical limitation of lidocaine is that it wears off relatively quickly, typically within one to two hours. For wound repair, this means a patient’s pain can return well before the wound has settled down. A randomized trial comparing lidocaine to bupivacaine for laceration repair found that pain scores in the lidocaine group climbed back toward pre-anesthesia levels within about two hours, while the bupivacaine group maintained low pain scores for five hours or more.19Annals of Emergency Medicine. Lidocaine Versus Bupivacaine in the Evaluation of Lacerations A separate study focused on post-procedural pain also found bupivacaine superior to lidocaine for sustained relief.20PubMed Central. Comparison of bupivacaine and lidocaine use for postoperative pain control in endodontics
Bupivacaine is not always preferable. It has a higher potential for cardiac toxicity if accidentally injected into a blood vessel, and it is not available in the same over-the-counter forms as lidocaine. But if you are being treated for a wound that will hurt after the repair is done, it is worth asking whether a longer-acting anesthetic is an option.
Lidocaine and Nerve Regeneration
For wounds involving nerve damage, there is an interesting wrinkle. Electrical stimulation therapy is sometimes used to accelerate nerve regeneration after a nerve has been cut and repaired surgically. A rat study found that applying lidocaine as a nerve block before the electrical stimulation completely negated the regenerative benefit, essentially blocking the therapeutic signal that the stimulation was designed to deliver.21PubMed Central. Lidocaine Nerve Block Diminishes the Effects of Therapeutic Electrical Stimulation to Enhance Nerve Regeneration in Rats Importantly, though, the same research group later showed that applying lidocaine after the electrical stimulation session did not interfere with the regenerative effects, and lidocaine applied without any electrical stimulation context did not damage healthy or injured nerves.22PubMed Central. Electrical Stimulation Therapy to Accelerate Nerve Regeneration Remains Effective Following Postoperative Application of Lidocaine The concern is specific to timing: lidocaine during a therapeutic nerve stimulation session undermines the therapy, but lidocaine for pain control afterward does not.
This distinction matters most for hand surgery patients and others recovering from nerve injuries who are receiving both electrical stimulation therapy and local anesthetics. For ordinary wound care, lidocaine does not appear to pose a meaningful threat to nerve healing on its own.